Manjari Rani Regmi
Overview
Explore the profile of Manjari Rani Regmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regmi M, Bhattarai M, Parajuli P, Botchway A, Tandan N, Abdelkarim J, et al.
Curr Cardiol Rev
. 2022 Dec;
19(3):e051222211571.
PMID: 36475341
Objectives: This meta-analysis aims to investigate the recurrence of atrial fibrillation (AF) post-ablation based on the various stages of fibrosis seen in the late gadolinium enhancement magnetic resonance imaging (LGE-MRI)....
2.
Regmi M, Tandan N, Parajuli P, Bhattarai M, Maini R, Kulkarni A, et al.
Clin Med Res
. 2021 Sep;
19(3):116-122.
PMID: 34531268
The objective of our study was to use the parameters of social vulnerability index (SVI) to observe their association with the 30-day hospital readmissions in the heart failure population. Data...
3.
Regmi M, Parajuli P, Tandan N, Bhattarai M, Maini R, Garcia O, et al.
Ir J Med Sci
. 2021 Mar;
191(1):205-211.
PMID: 33712979
Background: The objective of our study is to retrospectively investigate if the HOSPITAL score, LACE index, and RAHF scale exhibit any bias based on gender and race in heart failure...
4.
Parajuli P, Regmi M, Lara-Garcia O, Abu Limon I, Deckard A
J Community Hosp Intern Med Perspect
. 2020 Aug;
10(4):361-364.
PMID: 32850099
Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB...
5.
Parajuli P, Lara-Garcia O, Regmi M, Skoza W, Bhattarai M, Kulkarni A, et al.
Medicines (Basel)
. 2020 May;
7(5).
PMID: 32443705
The pharmacologic management of heart failure with preserved ejection fraction (HFpEF) involves far fewer options with demonstrated additional benefit. Therefore, we examined the effect of combination of multiple classes of...
6.
Regmi M, Bhattarai M, Parajuli P, Garcia O, Tandan N, Ferry N, et al.
Clin Med Res
. 2020 Apr;
18(4):126-132.
PMID: 32340982
Objective: Several studies identify heart failure (HF) as a potential risk for hospital readmission; however, studies on predictability of heart failure readmission is limited. The objective of this work was...